KSB Ltd Q1 FY27 Results Analysis: PAT Plunges 18.75%, EBITDA Margin Compresses 184 bps

CompoundingAI Research Updated August 04, 2026 2 min read
Negative

KSB Ltd's Q1 FY27 numbers came in soft, with revenue of Rs. 690.70 Cr (+3.60% YoY) and PAT growth of -18.75% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateAugust 04, 2026
QuarterQ1 FY 2026-2027
Revenue (Q1)Rs. 690.70 Cr (+3.60% YoY)
PAT (Q1)Rs. 57.20 Cr (-18.75% YoY)
EBITDA margin12.42% (-184 bps YoY)
EPS (Q1)Rs. 3.29 (-18.56% YoY)
Market capRs. 14,908.20 Cr
CMPRs. 856.95

Quarter Snapshot

KSB's Q1 FY27 results showed modest revenue growth of 3.6% YoY, but profitability declined sharply with PAT down 18.75% and EBITDA margin contracting 184 bps. The valves segment experienced a severe margin collapse, and working capital absorption turned free cash flow deeply negative. The company's performance lagged the strong IIP capital-goods momentum, indicating potential market share loss. No management guidance was provided in the filing.

Key Investment Insights

Key Positives

  • Revenue grew 3.6% YoY to Rs.690.70 Cr.
  • COGS ratio improved 56 bps YoY to 54.70%.
  • Pumps segment revenue grew 5.41% YoY with margin holding steady at 11.19%.
  • Sequential revenue growth of 14.87% QoQ.
  • Associate profit share increased 13.51% YoY to Rs.4.20 Cr.

Risk Factors

  • Consolidated PAT declined 18.75% YoY to Rs.57.20 Cr.
  • EBITDA margin contracted 184 bps YoY to 12.42%.
  • Valves segment EBIT margin collapsed from 15.31% to 4.07% YoY.
  • Operating cash flow was only Rs.15.50 Cr for H1 FY27, with CFO/PAT ratio of 0.16x.
  • Inventories surged 22.25% since Dec 2025, absorbing Rs.174.90 Cr in working capital.
  • Employee costs grew 15.86% YoY, outpacing revenue growth by a wide margin.
Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.

Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings

Login Now